跳至主要内容
临床试验/NCT06008782
NCT06008782招募中不适用

HEARS-SLP: Providing Speech Language Pathologist-Delivered Hearing Health Care to Individuals With Cognitive Impairment

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Change from Baseline in Neuropsychiatric Symptoms as assessed by the Neuropsychiatric Inventory (NPI-Q)

研究概览

简要总结

Building upon the HEARS audiologist-community health worker (CHW) model, this study intervention will be delivered by a speech-language pathologist (SLP). The primary objective of the study is to develop and test an affordable and accessible hearing rehabilitative intervention that will be delivered by a SLP to individuals with cognitive impairment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
60 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 60 - 100 years old
  • English-speaking
  • Lives at home
  • Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
  • Availability of caregiver/study partner to participate in all study-related visits and who provides ≥8 hours of weekly oversight/care
  • Speech frequency pure tone average (0.5- 4 kHz) >25 db in the better-hearing ear; adult onset hearing loss
  • Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms

排除标准

  • Current self-reported use of hearing aid or amplification device
  • Medical contraindication to use hearing aids ( e.g. draining ears)
  • Inability to participate in the 1-month follow up

研究组 & 干预措施

Immediate treatment

Experimental

immediate treatment

干预措施: HEARS-SLP program (Behavioral)

Delayed treatment

Placebo Comparator

1 month delayed treatment

干预措施: HEARS-SLP program (Behavioral)

Delayed treatment

Placebo Comparator

1 month delayed treatment

干预措施: HEARS-SLP device (Device)

Immediate treatment

Experimental

immediate treatment

干预措施: HEARS-SLP device (Device)

结局指标

主要结局

Change from Baseline in Neuropsychiatric Symptoms as assessed by the Neuropsychiatric Inventory (NPI-Q)

时间窗: Baseline and 1 month post-intervention (immediate group). 1 month post-baseline (Delayed Group)

Scoring: Each of the 12 NPI-Q domains contains a survey question that reflects symptoms of that domain. Initial responses to each domain question are "Yes" or "No". If the response to the question is "No", the informant goes to the next question. If "Yes", the informant then rates both the Severity of the symptoms present within the last month on a 3-point scale and the associated impact of the symptom manifestations on them using a 5-point scale. The NPI-Q provides symptom Severity and Distress ratings for each symptom reported, and total Severity and Distress scores reflecting the sum of individual domain scores. Total NPI-Q severity score is the sum of individual symptom scores, ranges from 0 to 36. SEVERITY of the symptom (how it affects the patient): 1. = Mild (noticeable, but not a significant change) 2. = Moderate (significant, but not a dramatic change) 3. = Severe

次要结局

  • Change From Baseline in Hearing Specific Quality of life as assessed by the Hearing Handicap Inventory for the Elderly (HHIE-S)(Baseline and 1 month post-intervention (immediate group). 1 month post-baseline (Delayed Group))
  • Change from Baseline in Health-related Quality of Life as assessed by the Quality of Life in Alzheimer's Disease (QOL-AD) scale(Baseline and 1 month post-intervention (immediate group). 1 month post-baseline (Delayed Group))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

HEARS-SLP: Providing SLP-Delivered Hearing Health... | 临床试验